MUFG Securities EMEA plc Has $9.67 Million Holdings in Humana Inc. $HUM

MUFG Securities EMEA plc lifted its position in shares of Humana Inc. (NYSE:HUM) by 1,539.3% during the 4th quarter, Holdings Channel.com reports. The firm owned 37,736 shares of the insurance provider’s stock after purchasing an additional 35,434 shares during the quarter. MUFG Securities EMEA plc’s holdings in Humana were worth $9,665,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of the company. Sound View Wealth Advisors Group LLC grew its holdings in shares of Humana by 3.5% during the 4th quarter. Sound View Wealth Advisors Group LLC now owns 1,060 shares of the insurance provider’s stock worth $272,000 after purchasing an additional 36 shares in the last quarter. Unison Advisors LLC grew its holdings in shares of Humana by 0.4% during the 3rd quarter. Unison Advisors LLC now owns 10,137 shares of the insurance provider’s stock worth $2,646,000 after purchasing an additional 37 shares in the last quarter. CoreCap Advisors LLC grew its holdings in shares of Humana by 54.4% during the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 37 shares in the last quarter. Insigneo Advisory Services LLC grew its holdings in shares of Humana by 3.0% during the 3rd quarter. Insigneo Advisory Services LLC now owns 1,484 shares of the insurance provider’s stock worth $386,000 after purchasing an additional 43 shares in the last quarter. Finally, Columbus Macro LLC grew its holdings in shares of Humana by 5.5% during the 4th quarter. Columbus Macro LLC now owns 821 shares of the insurance provider’s stock worth $210,000 after purchasing an additional 43 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Price Performance

Shares of HUM stock opened at $305.97 on Monday. The stock’s fifty day simple moving average is $231.96 and its 200 day simple moving average is $228.98. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77. The firm has a market cap of $36.73 billion, a price-to-earnings ratio of 32.72, a P/E/G ratio of 2.21 and a beta of 0.76. Humana Inc. has a one year low of $163.11 and a one year high of $315.66.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, beating the consensus estimate of $9.97 by $0.34. The business had revenue of $39.65 billion for the quarter, compared to analyst estimates of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.Humana’s quarterly revenue was up 23.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $11.58 EPS. Humana has set its FY 2026 guidance at 9.000- EPS. On average, analysts expect that Humana Inc. will post 9.01 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $3.54 annualized dividend and a yield of 1.2%. Humana’s payout ratio is currently 37.86%.

Analyst Ratings Changes

Several analysts have recently weighed in on the company. Morgan Stanley lifted their price objective on Humana from $146.00 to $217.00 and gave the stock an “underweight” rating in a report on Friday, May 15th. Weiss Ratings reissued a “sell (d+)” rating on shares of Humana in a report on Tuesday, April 21st. Wells Fargo & Company lowered Humana from a “cautious” rating to a “reduce” rating in a report on Wednesday, May 20th. Wolfe Research lowered Humana from a “strong-buy” rating to a “peer perform” rating in a report on Wednesday, May 20th. Finally, Robert W. Baird decreased their price target on Humana from $264.00 to $205.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 15th. Nine analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and four have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Humana has a consensus rating of “Hold” and a consensus price target of $270.48.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.